Literature DB >> 27873166

A dangerous hobby? Erysipelothrix rhusiopathiae bacteremia most probably acquired from freshwater aquarium fish handling.

E Asimaki1, O Nolte2, G Overesch3, C Strahm4.   

Abstract

Erysipelothrix rhusiopathiae is a facultative anaerobic Gram-positive rod that occurs widely in nature and is best known in veterinary medicine for causing swine erysipelas. In humans, infections are rare and mainly considered as occupationally acquired zoonosis. A case of E. rhusiopathiae bacteremia most likely associated with home freshwater aquarium handling is reported. The route of transmission was probably a cut with the dorsal fin of a dead pet fish. A short review of clinical presentations, therapeutic considerations and pitfalls of E. rhusiopathiae infections in humans is presented.

Entities:  

Keywords:  Bacteremia; Endocarditis; Erysipelothrix rhusiopathiae; Fish; Freshwater aquarium

Mesh：

Year:  2016        PMID： 27873166     DOI： 10.1007/s15010-016-0966-z

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  22 in total

1.  Chronic monoarthritis of the knee in systemic lupus erythematosus.

Authors:  R C C Wong; K O Kong; R V T P Lin; T Barkham
Journal:  Lupus       Date:  2003       Impact factor: 2.911

2.  Erysipelothrix rhuseopathiae septicaemia with prolonged hypotension: a case report.

Authors:  Soondal Koomar Surrun; Fazlur Rehman Jaufeerally; H C James Sim
Journal:  Ann Acad Med Singapore       Date:  2008-03       Impact factor: 2.473

3.  First report of macrolide resistance gene erm(T) harbored by a novel small plasmid from Erysipelothrix rhusiopathiae.

Authors:  Chang-Wen Xu; An-Yun Zhang; Chun-Mei Yang; Yun Pan; Zhong-Bin Guan; Chang-Wei Lei; Lin-Yao Peng; Qing-Zhou Li; Hong-Ning Wang
Journal:  Antimicrob Agents Chemother       Date:  2015-02-09       Impact factor: 5.191

4.  Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

Authors:  Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Sheldon L Kaplan; Jose G Montoya; James C Wade
Journal:  Clin Infect Dis       Date:  2014-07-15       Impact factor: 9.079

5.  Risk of infectious complications in patients taking glucocorticosteroids.

Authors:  A E Stuck; C E Minder; F J Frey
Journal:  Rev Infect Dis       Date:  1989 Nov-Dec

6.  Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.

Authors:  Daniel S Olsson; Eva Andersson; Ing-Liss Bryngelsson; Anna G Nilsson; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2014-11-06       Impact factor: 5.958

Review 7.  Erysipelothrix rhusiopathiae endocarditis: microbiologic, epidemiologic, and clinical features of an occupational disease.

Authors:  G L Gorby; J E Peacock
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

Review 8.  Erysipelothrix rhusiopathiae.

Authors:  Qinning Wang; Barbara J Chang; Thomas V Riley
Journal:  Vet Microbiol       Date:  2009-08-08       Impact factor: 3.293

9.  Erysipelothrix Rhusiopathiae Bacteremia without Endocarditis: Rapid Identification from Positive Blood Culture by MALDI-TOF Mass Spectrometry. A Case Report and Literature Review.

Authors:  Luigi Principe; Silvia Bracco; Carola Mauri; Silvia Tonolo; Beatrice Pini; Francesco Luzzaro
Journal:  Infect Dis Rep       Date:  2016-03-21

10.  Nonspecific Erysipelothrix rhusiopathiae Bacteremia in a Patient with Subclinical Alcoholic Liver Disease.

Authors:  Asim Ahmed Kichloo; Alexander Hallac; Ben Mousavi; Omkar Hirekhan
Journal:  Case Rep Infect Dis       Date:  2013-05-30
View more
  1 in total

1.  Clinical manifestations, associated diseases, diagnosis, and treatment of human infections caused by Erysipelothrix rhusiopathiae: a systematic review.

Authors:  Mosayeb Rostamian; Donya Rahmati; Alisha Akya
Journal:  Germs       Date:  2022-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.